MILLENNIUM MANAGEMENT LLC - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 37 filers reported holding CATALYST BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$56
-45.6%
272,313
+39.6%
0.00%
Q4 2022$103
-100.0%
195,022
-78.2%
0.00%
Q3 2022$451,000
-24.8%
894,722
+165.2%
0.00%
Q2 2022$600,000
+42.5%
337,334
-47.1%
0.00%
Q1 2022$421,000
-49.3%
637,799
-29.9%
0.00%
Q4 2021$831,000
-69.9%
909,238
+35.5%
0.00%
-100.0%
Q3 2021$2,759,000
-19.1%
671,224
-14.8%
0.00%0.0%
Q2 2021$3,411,000
+25.5%
787,748
+46.1%
0.00%0.0%
Q1 2021$2,718,000
-37.0%
539,274
-21.2%
0.00%
-33.3%
Q4 2020$4,316,000
+5.7%
683,930
-28.0%
0.00%
-40.0%
Q3 2020$4,085,000
-44.0%
949,935
-23.6%
0.01%
-50.0%
Q2 2020$7,298,000
+52.1%
1,243,337
+13.3%
0.01%
-9.1%
Q1 2020$4,798,000
-1.8%
1,097,837
+53.0%
0.01%
+83.3%
Q4 2019$4,885,000
+41.5%
717,365
+2.0%
0.01%
+20.0%
Q3 2019$3,453,000
-17.7%
703,346
+23.5%
0.01%
-16.7%
Q2 2019$4,196,000
-8.5%
569,309
+0.7%
0.01%
-14.3%
Q1 2019$4,585,000
+98.4%
565,341
+93.1%
0.01%
+75.0%
Q4 2018$2,311,000
-38.4%
292,840
-15.8%
0.00%
-20.0%
Q3 2018$3,750,000
+50.2%
347,834
+62.6%
0.01%
+66.7%
Q2 2018$2,496,000
+54.1%
213,903
+240.6%
0.00%
+50.0%
Q1 2018$1,620,00062,8000.00%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,076,376$13,321,0006.97%
22NW, LP 1,429,242$6,189,0001.66%
Ghost Tree Capital, LLC 1,000,000$4,330,0001.19%
ACUTA CAPITAL PARTNERS, LLC 685,000$2,966,0001.18%
Sio Capital Management, LLC 623,892$2,701,0000.67%
Parkman Healthcare Partners LLC 393,449$1,704,0000.37%
Nantahala Capital Management 2,531,360$10,961,0000.31%
AlphaCentric Advisors LLC 182,500$790,0000.22%
Ikarian Capital, LLC 581,200$2,518,0000.20%
Tibra Equities Europe Ltd 79,200$343,0000.11%
View complete list of CATALYST BIOSCIENCES INC shareholders